PMPM

Investor Alert (NYSE: AGL): Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against agilon health, inc. With Expanded Class Period and Encourages Investors With Substantial Losses to Contact the Firm

Retrieved on: 
Monday, March 25, 2024

Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.

Key Points: 
  • Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 28, 2024

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2023, and affirmed its 2024 guidance.

Key Points: 
  • P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2023, and affirmed its 2024 guidance.
  • “Top line results for 2023 were strong as the team executed and delivered with revenue of approximately $1.27 billion, representing 21% growth and exceeding the top end of our guidance range.
  • We are reaffirming our 2024 outlook based on several key observations in the early part of the year including strong growth in membership, increased funding, and stabilized medical cost trends,” said Dr. Sherif Abdou, CEO of P3.
  • “Beginning in January 2024, we have seen a return to a more normalized seasonally adjusted utilization.”

Investor Alert (NYSE: AGL): Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against agilon health, inc. With Expanded Class Period and Encourages Investors With Substantial Losses to Contact the Firm

Retrieved on: 
Monday, March 25, 2024

Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.

Key Points: 
  • Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

COPE Health Solutions and the Analytics for Risk Contracting Platform Collaborate with Findhelp to Bring Market Leading HRSN Solutions to New York

Retrieved on: 
Friday, March 8, 2024

The Findhelp and ARC solution will enable SCNs to improve quality and total cost of care outcomes by closing health equity gaps and improving care plan adherence.

Key Points: 
  • The Findhelp and ARC solution will enable SCNs to improve quality and total cost of care outcomes by closing health equity gaps and improving care plan adherence.
  • Findhelp’s platform offers unrivaled capabilities for completing Health Related Social Needs (HRSN) screening, matching the needs of the population to the right CBO solution, and facilitating closed-loop referrals to CBOs.
  • The platform also allows providers and CBOs to handle case management, claims management, and payment for HRSN services all in one place.
  • ARC’s analytics help to understand specific funding initiatives to report and compare outcomes and ROI across HRSN services and CBOs.

XpertDox and Cucamonga Valley Medical Group Announce Partnership for AI-Enabled Medical Coding

Retrieved on: 
Thursday, February 22, 2024

BIRMINGHAM, Ala., Feb. 22, 2024 /PRNewswire/ -- XpertDox, a pioneer in autonomous AI-enabled medical coding, is proud to announce its strategic partnership with Cucamonga Valley Medical Group, Inc. (CVMG), a top-tier primary care organization from California. This collaboration introduces XpertCoding, XpertDox's AI medical coding software, into CVMG's healthcare coding operations across all facilities and providers, revolutionizing their coding quality and revenue cycle process.

Key Points: 
  • XpertDox has partnered with Cucamonga Valley Medical Group to integrate XpertCoding, XpertDox's automated AI medical coding platform, into CVMG's primary care operations
    BIRMINGHAM, Ala., Feb. 22, 2024 /PRNewswire/ -- XpertDox , a pioneer in autonomous AI-enabled medical coding, is proud to announce its strategic partnership with Cucamonga Valley Medical Group, Inc. (CVMG), a top-tier primary care organization from California.
  • This collaboration introduces XpertCoding , XpertDox's AI medical coding software, into CVMG's healthcare coding operations across all facilities and providers, revolutionizing their coding quality and revenue cycle process.
  • Melissa Ferro, Director of Quality and Compliance at CVMG, emphasized, "The adoption of XpertCoding's AI-enabled medical coding software into our coding workflow marks a pivotal advancement.
  • For more information about XpertCoding's AI-enabled autonomous medical coding software, connect with XpertDox at [email protected] or call 205-259-6045.

IntegraNet Health Unveils the "WholeHealth Solution"

Retrieved on: 
Tuesday, January 23, 2024

HOUSTON, Jan. 23, 2024 /PRNewswire/ -- IntegraNet Health, a prominent Independent Practice Association (IPA) and Management Service Organization (MSO) with a 27-year population health management history in Texas and the Southeast United States, is proud to announce the development and imminent release of the revolutionary WholeHealth Solution. This innovative consumer-based platform represents a paradigm shift in healthcare delivery by integrating consumers with their chosen providers, employers, health plans, care givers and lifestyle coaches, and by providing the latest science and technology to enhance patient engagement, streamline care coordination, and improve health outcomes.

Key Points: 
  • Improved Health Plan and Employer Relations: Enhanced consumer loyalty leads to a deeper dependence on IntegraNet Health, translating to improved client loyalty for contracted Health Plans and Employers.
  • This marks the first fully integrated consumer-based health platform in the U.S. powered by AI and Blockchain technology, and showcases IntegraNet Health's commitment to transforming healthcare.
  • IntegraNet Health, formerly IntegraNet Physician Resource, Inc., is a leading Independent Practice Association and Management Service Organization Health with a 27-year profitable history in Texas and the Southeast United States.
  • IntegraNet Health has been a pioneer in developing value-based health services and has partnered with many nationally recognized Health Plans, including long term contracts with Aetna Health, Anthem Health, Amerigroup, Blue Cross of Texas, Bravo Health, Cigna Health, Community Health Choice, Evercare, Humana, Oscar Health, SelectCare of Texas, Wellcare, Wellpoint, and SCAN Health.

P3 Health Partners Announces Third-Quarter and Year-to-Date 2023 Results

Retrieved on: 
Wednesday, November 8, 2023

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2023.

Key Points: 
  • P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2023.
  • “Our results for the third quarter show the continued improvement of the business as providers and patients mature on our platform.
  • All key metrics are tracking as expected and net cash used in operating activities has improved to negative $8 million for the quarter.
  • We are re-affirming our existing full-year 2023 guidance and providing preliminary 2024 full-year Adjusted EBITDA guidance of $20 million to $40 million,” said Dr. Sherif Abdou, CEO of P3.

New Data Shows Thyme Care Navigation Program Reduces Total Cost of Care for Cancer Patients by Nearly 20%

Retrieved on: 
Tuesday, October 31, 2023

In a retrospective study of patients undergoing cancer treatment, participation in Thyme Care's virtual cancer care navigation program resulted in a $594 reduction in total costs per month for navigated patients compared to a control group.

Key Points: 
  • In a retrospective study of patients undergoing cancer treatment, participation in Thyme Care's virtual cancer care navigation program resulted in a $594 reduction in total costs per month for navigated patients compared to a control group.
  • This study shows that a cancer navigation program can reduce overall costs when deployed in collaboration with a health plan, and demonstrates that third-party virtual navigation can reduce overall medical costs for cancer populations.
  • In collaboration with a large Medicare Advantage health plan, Thyme Care launched a scalable, independent virtual care navigation program designed to reduce total cost of care for the health plan's cancer population.
  • Thyme Care's proactive, patient-centric approach to cancer care was responsible for reducing total cost of care per patient by $594 PMPM relative to control participants who did not participate in the program.

Ontrak Health Achieves $750 Per Member Per Month (PMPM) Cost Savings for Prominent Health Plan’s Medicaid Members with WholeHealth+ Program

Retrieved on: 
Thursday, October 19, 2023

Ontrak Health (NASDAQ: OTRK), a leading AI-powered and telehealth-enabled healthcare company, is proud to announce the promising results of a formal evaluation conducted on the Ontrak WholeHealth+ program.

Key Points: 
  • Ontrak Health (NASDAQ: OTRK), a leading AI-powered and telehealth-enabled healthcare company, is proud to announce the promising results of a formal evaluation conducted on the Ontrak WholeHealth+ program.
  • The evaluation aimed to assess the program's impact on one of its health plan customer’s Medicaid members' medical costs, and the preliminary findings are encouraging and validates the impact of our program to our customers.
  • This outcome underscores the remarkable effectiveness of the WholeHealth+ program in reducing healthcare expenditures while improving patient outcomes.
  • It also adds results for Medicaid members in addition to previously measured Medicare and Commercial member savings of $485 PMPM as part of Ontrak Health’s independently validated 2021 Treatment Effect Study.

Medicaid Plans Core Administrative Expense Growth Decelerates in 2022

Retrieved on: 
Tuesday, October 10, 2023

Core expenses exclude the plans’ Sales and Marketing expense clusters.

Key Points: 
  • Core expenses exclude the plans’ Sales and Marketing expense clusters.
  • Navigator excerpts from the 2023 Medicaid edition of Sherlock Benchmarks which analyzes and reports on the in-depth surveys of 15 Medicaid plans that collectively served 15.5 million members with Comprehensive products.
  • With other universes, the Sherlock Benchmarks universes analyze the administrative costs of plans serving 17% of all Medicaid beneficiaries.
  • Besides the Medicaid universe, others include Blue Cross Blue Shield plans, Independent/Provider-Sponsored plans and Medicare plans.